1[1]Ferrara N,Davis-Smyth T.The biology of vascular endothelial growth factor[J].Endocr Rev,1997,18(1):4.
2[2]Kurebayashi J,Otsuki T,Kunisue H,et al.Expression of vascular endothelial growth factor(VEGF) family members in breast cancer[J].Jpn J Cancer Res,1999,90(9):977.
3[3]Kroll J,Waltenberger J.A novel function of VEGF receptor-2(KDR):rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells [J].Biochem Biophys Res Commun,1999,265 (3):636.
5[5]Waltenberger J,Mayr U,Pentz S,et al.Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia[J].Circulation,1996,94 (7):1647.
6[6]Asano M,Kaneoka K,Nomura T,et al.Increase in serum vascular endothelial growth factor levels during altitude training [J].Acta Physiol Scand,1998,162(4):455.
7[7]Fujiwara T,Nishizaki M,Tanaka N,et al.Recombinant adenovirus expressing wild-type p53 is antiagiogenic-implication for lung cancer gene therapy [J].Gan To Kagaku Ryoho,2000,27(8):1217.
8[8]Munshi N,Groopman JE,Gill PS,et al.c-Sro mediates mitogenic signals and associates with cytoskeletal proteins upon vascular endothelial growth factor stimulation in Kaposi′s sarcoma cells[J].J Immunol,2000,164 (3):1169.
9[9]Mukhopadhyay D,Tsiokad L,Vikas P,et al.Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression[J].Cancer Res,1995,55:6161.
10[10]Pupilli C,Lasagni L,Romagnani P,et al.Angiotensin Ⅱ stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells[J].J Am Soc Nephrol,1999,10(2):245.
3Borgstrom P, Hillan K J, Sriramarao P,et al. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing anti-body[J].Cancer Res,1996,56(17):4032～4039.
4Tomisaki SL, Ohno S. Microvessel quantification and its possible relation with liver metastasis in colorectal cancer[J].Cancer,1996,77(9):1722～1728.
5Nicosia RF. What is the role of vascular endothelial growth factor related molecules in angiogenesis[J].Am J Path,1998,153(1):11～16.
6Park JE, Keller GA, Ferrara N, et al. The vascular endothelial growth factor(VEGF) is of forms: differential deposition into the subeithelial extracelluar matrix and Park bioactivity of extracelluar maxtrix-bound VEGF[J].Mol Biol Cell,1993,4(12):1317～1326.
7Yamamoto Y, Toi M, Kondo S, et al. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients[J]. Clin Cancer Res,1996,2(5):821～826.
8Salven P, Teerenhovi L, Joensum H .A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma[J]. Blood,1997, 90(8):3167～3172.
9Bertolini F, Paolucci M, Paccatori F, et al. Angiogence growth factor and endostatin in non-Hodgkin's lymphoma[J]. Br J Haematol,1999,106(2):504～509.
10Leung DW,Cachianes G,Kuang WJ,et al.Vascular endothelial growth factor is a secreted angiogenic mitogen[J].Science,1989,246:1306～1309.
